The United Kingdom is witnessing a significant surge in interest surrounding mind-altering substances. Beyond the common use of psilocybin and LSD, researchers and explorers are increasingly exploring less-charted territories, particularly copyright and the budding cannabinoid, CBG compound. The evolving community encompasses therapeutic research i